Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trial

[1]  R. Duran,et al.  Safety and Efficacy of Ipilimumab plus Nivolumab and Sequential Selective Internal Radiation Therapy in Hepatic and Extrahepatic Metastatic Uveal Melanoma , 2022, Cancers.

[2]  M. Weichenthal,et al.  Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity , 2022, Cancers.

[3]  C. Gebhardt,et al.  Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance? , 2021, Cancers.

[4]  M. Weichenthal,et al.  Clinical determinants of long-term survival in metastatic uveal melanoma , 2021, Cancer Immunology, Immunotherapy.

[5]  M. Weichenthal,et al.  Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis , 2021, Cancers.

[6]  F. Wacker,et al.  Chemosaturation with Percutaneous Hepatic Perfusion: Outcome and Safety in Patients with Metastasized Uveal Melanoma Chemosaturation durch perkutane hepatische Perfusion mit Melphalan bei hepatisch metastasiertem Aderhautmelanom: eine Überlebens- und Sicherheitsanalyse , 2021, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[7]  J. Becker,et al.  Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy , 2021, Nature communications.

[8]  K. Lindblad,et al.  Liver metastases inhibit immunotherapy efficacy , 2021, Nature medicine.

[9]  R. Sullivan,et al.  Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study , 2020, Journal for immunotherapy of cancer.

[10]  B. Loveday,et al.  Systematic review of liver directed therapy for uveal melanoma hepatic metastases. , 2019, HPB.

[11]  J. Utikal,et al.  Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study , 2019, Journal of Immunotherapy for Cancer.

[12]  I. Chervoneva,et al.  A Prospective Phase II Trial of Radioembolization for Treatment of Uveal Melanoma Hepatic Metastasis. , 2019, Radiology.

[13]  P. Huppert,et al.  Meta-Analysis in Metastatic Uveal Melanoma to Determine Progression-Free and Overall Survival Benchmarks: an International Rare Cancers Initiative (IRCI) Ocular Melanoma study. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[14]  L. de Geus-Oei,et al.  Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial , 2019, CardioVascular and Interventional Radiology.

[15]  M. Manns,et al.  Percutaneous hepatic perfusion (chemosaturation) with melphalan in patients with intrahepatic cholangiocarcinoma: European multicentre study on safety, short-term effects and survival , 2018, European Radiology.

[16]  B. Stedman,et al.  Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease , 2017, Journal of surgical oncology.

[17]  Johannes Griss,et al.  Tumor-associated B-cells induce tumor heterogeneity and therapy resistance , 2017, Nature Communications.

[18]  Arun D. Singh,et al.  Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013) , 2017, Ocular Oncology and Pathology.

[19]  M. Manns,et al.  Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors , 2017, Journal of Cancer Research and Clinical Oncology.

[20]  D. Schadendorf,et al.  Immunotherapy in melanoma: Recent advances and future directions. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  Arun D. Singh,et al.  Laparoscopic management of liver metastases from uveal melanoma , 2016, Surgical Endoscopy.

[22]  V. Servois,et al.  Radiofrequency ablation and surgical resection of liver metastases from uveal melanoma. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  C. Nutting,et al.  Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases , 2016, Annals of Surgical Oncology.

[24]  S. Demaria,et al.  Role of Local Radiation Therapy in Cancer Immunotherapy. , 2015, JAMA oncology.

[25]  H. Ishwaran,et al.  Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer , 2015, Nature.

[26]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[27]  G. Long,et al.  Site‐specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti–PD‐1 therapy , 2019, Cancer.

[28]  R. Scully,et al.  Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. , 2001, Archives of ophthalmology.